Anti-Müllerian hormone as an ovarian reserve marker in young cancer women who undergo ovarian tissue cryopreservation

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum. Reprod. Update 8(2), 141–154 (2002).
  MedlineGoogle Scholar
• 2 Anderson RA. What does anti-Müllerian hormone tell you about ovarian function? Clin. Endocrinol. (Oxford) 77(5), 652–655 (2012).• Examines and discusses the role of anti-Müllerian hormone (AMH) in the various aspects of ovarian function and dysfunction.
  Medline CASGoogle Scholar
• 3 Hansen KR, Morris JL, Thyer AC, Soules MR. Reproductive aging and variability in the ovarian antral follicle count: application in the clinical setting. Fertil. Steril. 80(3), 577–583 (2003).
  MedlineGoogle Scholar
• 4 Broekmans FJ, de Ziegler D, Howles CM, Gougeon A, Trew G, Olivennes F. The antral follicle count: practical recommendations for better standardization. Fertil. Steril. 94(3), 1044–1051 (2010).
  MedlineGoogle Scholar
• 5 Deb S, Campbell BK, Clewes JS, Pincott-Allen C, Raine-Fenning NJ. Intra-cycle variation in the number of antral follicles stratified by size and in endocrine markers of ovarian reserve in women with normal ovulatory menstrual cycles. Ultrasound Obstet. Gynecol. 41(2), 216–222 (2013).
  Medline CASGoogle Scholar
• 6 Baarends WM, Uilenbroek JT, Kramer P et al. Anti-Müllerian hormone and anti-Müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 136(11), 4951–4962 (1995).
  Medline CASGoogle Scholar
• 7 Weenen C, Laven JS, Von Bergh AR et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol. Hum. Reprod. 10(2), 77–83 (2004).
  Medline CASGoogle Scholar
• 8 Durlinger ALL, Gruijters MJ, Kramer P et al. Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142(11), 4891–4899 (2001).
  Medline CASGoogle Scholar
• 9 Durlinger ALL, Gruijters MJ, Kramer P et al. Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 143(3), 1076–1084 (2002).
  Medline CASGoogle Scholar
• 10 Carlsson IB, Scott JE, Visser JA, Ritvos O, Themmen AP, Hovatta O. Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Hum. Reprod. 21(9), 2223–2227 (2006).
  Medline CASGoogle Scholar
• 11 Seifer DB, Maclaughlin DT. Mullerian inhibiting substance is an ovarian growth factor of emerging clinical significance. Fertil. Steril. 88(3), 539–546 (2007).
  Medline CASGoogle Scholar
• 12 Grossman P, Nakajima ST, Fallat ME, Siow Y. Mullerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture. Fertil. Steril. 89(5 Suppl.), 1364–1370 (2008).
  Medline CASGoogle Scholar
• 13 Takahashi M, Koide SS, Donahoe PK. Mullerian inhibiting substance as oocyte meiosis inhibitor. Mol. Cell Endocrinol. 47(3), 225–234 (1986).
  Medline CASGoogle Scholar
• 14 de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil. Steril. 77(2), 357–362 (2002).
  MedlineGoogle Scholar
• 15 van Rooij IA, Tonkelaar I, Broekmans FJ et al. Anti-Müllerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 11(6 Pt 1), 601–606 (2004).
  MedlineGoogle Scholar
• 16 van Rooij IA, Broekmans FJ, Scheffer GJ et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil. Steril. 83(4), 979–987 (2005).
  Medline CASGoogle Scholar
• 17 La Marca A, Stabile G, Artenisio AC, Volpe A. Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum. Reprod. 21(12), 3103–3107 (2006).
  Medline CASGoogle Scholar
• 18 Hansen KR, Hodnett GM, Knowlton N, Craig LB. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil. Steril. 95(1), 170–175 (2011).•• First study that assessed the relationship between common clinical tests of ovarian reserve and the true ovarian reserve determined by the ovarian primordial follicle number. Two of the tests, the ovarian antral follicle count and serum levels of AMH, were significantly correlated with the ovarian primordial follicle number, even after correcting for chronological age.
  MedlineGoogle Scholar
• 19 Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr. Rev. 17(2), 121–155 (1996).
  Medline CASGoogle Scholar
• 20 Macklon NS, Fauser BC. Follicle-stimulating hormone and advanced follicle development in the human. Arch. Med. Res. 32(6), 595–600 (2001).
  Medline CASGoogle Scholar
• 21 Lass A. Assessment of ovarian reserve: is there still a role for ovarian biopsy in the light of new data? Hum. Reprod. 19(3), 467–469 (2004).
  MedlineGoogle Scholar
• 22 Schmidt KL, Byskov AG, Nyboe Andersen A, Müller J, Yding Andersen C. Density and distribution of primordial follicles in single pieces of cortex from 21 patients and in individual pieces of cortex from three entire human ovaries. Hum. Reprod. 18(6), 1158–1164 (2003).
  Medline CASGoogle Scholar
• 23 Hagen CP, Aksglaede L, SØrensen K et al. Individual serum levels of anti-Müllerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study. Hum. Reprod. 27(3), 861–866 (2012).
  Medline CASGoogle Scholar
• 24 Lie Fong S, Visser JA, Welt CK et al. Serum anti-Mullerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J. Clin. Endocrinol. Metab. 97(12), 4650–4655 (2012).•• Reports the assessment of serum AMH levels performed in a single laboratory in a large cohort of healthy females ranging from infancy until the end of the reproductive period.
  Medline CASGoogle Scholar
• 25 Hagen CP, Aksglaede L, SØrensen K et al. Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J. Clin. Endocrinol. Metab. 95(11), 5003–5010 (2010).
  Medline CASGoogle Scholar
• 26 Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum. Reprod. 7(10), 1342–1346 (1992).
  Medline CASGoogle Scholar
• 27 La Marca A, Volpe A. The anti-Mullerian hormone and ovarian cancer. Hum. Reprod. Update 13(3), 265–273 (2007).
  Medline CASGoogle Scholar
• 28 Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, Te Velde ER, Broekmans FJ. Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J. Clin. Endocrinol. Metab. 91(10), 4057–4063 (2006).
  Medline CASGoogle Scholar
• 29 Grynberg M, Pierre A, Rey R et al. Differential regulation of ovarian anti-müllerian hormone (AMH) by estradiol through α- and β-estrogen receptors. J. Clin. Endocrinol. Metab. 97(9), e1649–e1657 (2012).
  Medline CASGoogle Scholar